These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

957 related items for PubMed ID: 17110233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract] [Full Text] [Related]

  • 5. Dapsone drug resistance in the MDT era.
    Roche PW, Neupane KD, Failbus SS, Butlin CR.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined therapy in leprosy.
    Gatti JC.
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V, al-Suwaid AR.
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR, Shrestha K, Pandey B, Walker SL.
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [Abstract] [Full Text] [Related]

  • 14. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR.
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S, Courtright P.
    Int Ophthalmol Clin; 2007 Jul; 47(3):87-101. PubMed ID: 17667278
    [No Abstract] [Full Text] [Related]

  • 17. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN, Ebenezer G, Rao GS, Natrajan MM, Balasundaram B.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK, Hazra SK, Chaudhury S, Chatterjee B.
    Indian J Lepr; 1984 Sep; 56(1):78-85. PubMed ID: 6548246
    [Abstract] [Full Text] [Related]

  • 19. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
    Ganapati R, Pai VV, Banerji U, Thomas J, Saha B.
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161
    [No Abstract] [Full Text] [Related]

  • 20. [Therapy of leprosy today].
    Bahmer FA, Menzel S.
    Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.